GlassScriptPhysician profile
Saman Javedan
NPI 1730155052
$12,619.57
in general payments reported to CMS, 2019-2025
20 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,794 · 2020: $849 · 2021: $1,363 · 2022: $1,364 · 2023: $2,031 · 2024: $1,210 · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,032 · Food and Beverage: $2,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,031.59 |
| Food and Beverage | $2,218.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,506.54 | 2020-2025 | Airo, Everest Spinal System |
| Insightec,INC | $3,452.77 | 2022-2025 | Exablate |
| Zimmer Biomet Holdings, INC. | $2,694.61 | 2019-2020 | |
| Boston Scientific Corporation | $948.44 | 2019-2021 | |
| Medtronic, INC. | $819.49 | 2021-2025 | Activa PC, Mazor X System |
| Abbott Laboratories | $394.57 | 2019-2025 | Infinity |
| Medtronic USA, INC. | $171.75 | 2019-2020 | |
| Abbvie INC. | $101.01 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $100.00 | 2019 | |
| Gt Medical Technologies, INC | $93.76 | 2021 | |
| Portola Pharmaceuticals, LLC | $51.94 | 2019-2020 | |
| 7d Surgical INC. | $50.84 | 2019 | |
| Integrity Implants INC. | $44.42 | 2019 | |
| Ge Healthcare | $42.26 | 2023 | |
| Siemens Medical Solutions USA, INC. | $37.62 | 2025 | Artis Pheno |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $27.49 | 2019 | |
| Globus Medical, INC. | $25.16 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.89 | 2023 | Andexxa |
| Providence Medical Technology, INC. | $16.02 | 2025 | |
| Integra Lifesciences Corporation | $15.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saman Javedan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.